At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
repetitive Transcranial Magnetic Stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Randomized, Single Blind, Crossover Study to Evaluate Treatment Effects Associated With the NeuroStar New Treatment Feature
In Brief
A clinical study evaluating repetitive Transcranial Magnetic Stimulation for Major Depressive Disorder. Completed, enrolled 40 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the comfort of the NeuroStar® Advanced Therapy System regular prescribed TMS protocol versus a New Feature.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMajor Depressive Disorder
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedSep 2022
Enrollment StartNov 2022
Primary CompletionSep 2023
TodayJul 2026
First PostedSep 10, 2022
Enrollment StartNov 7, 2022
Primary CompletionSep 27, 2023
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 3.8 years ago
Interventions
repetitive Transcranial Magnetic Stimulationdevice
the administration of a series of magnetic stimuli to the brain for the purpose of altering brain function